Iranian Journal of Pharmaceutical Sciences

Vol. 22 No. 1 (2026)

Formulation, Development, Characterization, and Cytotoxicity Study of Dasatinib Monohydrate Loaded Solid Self-Nano Emulsifying Drug Delivery System (SNEDDS) for Enhancement of Solubility and Oral Bioavailability DAS-Loaded Solid SNEDDS for Enhanced Solubility and Bioavailability

Iranian Journal of Pharmaceutical Sciences, Vol. 22 No. 1 (2026), 26 January 2026 , Page 164-179
https://doi.org/10.22037/ijps.v22i1.48617

Abstract

To improve the dissolution and solubility of dasatinib monohydrate (DAS), this study aimed to develop a solid self-nanoemulsifying drug delivery system (S-SNEDDS). Syloid 244FP was utilized as a solid carrier in this study to formulate and further develop liquid SNEDDS (L-SNEDDS) containing dasatinib monohydrate into a solid form. Based on the findings of the initial screening, nine batches of DAS-loaded SNEDDS were prepared using Tween 20, PEG 400, and Capryol 90 as surfactant, cosurfactant, and oil, respectively. Ternary phase diagrams were created for the chosen systems to determine the nanoemulsification region. The study demonstrates that the average globule size of the optimized batch of Self-Nanoemulsifying Drug Delivery Systems (SNEDDS) fell within the nanometric scale, with optimal Polydispersity Index (PDI) values. All batches also demonstrated rapid emulsification time, high drug loading efficiency, and good optical clarity. The development of uniform, spherical droplets smaller than 100 nm was demonstrated by TEM analysis. Over 90% of the DAS was released in about 120 minutes, according to in vitro DAS release from SNEDDS formulae. The optimized SNEDDS formulation was selected for conversion into solid SNEDDS (S-SNEDDS) using suitable solid carriers. The synthesized S-SNEDDS formulae were assessed for drug content, cytotoxicity, FTIR, in vitro dissolution, and micromeritic properties. It was discovered that S-SNEDDS formulations exhibited excellent flow characteristics, significant drug release, and elevated drug content. The MTT assay results indicate that DAS-S-SNEDDS exhibits a dose-dependent cytotoxic effect against the HL60 (Human Leukemia) cell line. Compared with standard cytotoxic agents, DAS-S-SNEDDS exhibits a significant, potent effect against the HL60 (Human Leukemia) cell line. In vitro drug release studies demonstrated a marked enhancement in the dissolution rate of DAS. These findings indicate that DAS-S-SNEDDS may serve as an effective strategy to enhance the oral bioavailability and solubility of DAS.

Keywords:
  • SNEDDS
  • Lipid-based drug delivery
  • Oral bioavailability
  • Nanoemulsion
  • Cytoxicity study
  • Solubility

How to Cite

Bavaskar, K., Shaikh, A. I., Jain, A. S., Morani, D. O., & Joshi, S. (2026). Formulation, Development, Characterization, and Cytotoxicity Study of Dasatinib Monohydrate Loaded Solid Self-Nano Emulsifying Drug Delivery System (SNEDDS) for Enhancement of Solubility and Oral Bioavailability: DAS-Loaded Solid SNEDDS for Enhanced Solubility and Bioavailability. Iranian Journal of Pharmaceutical Sciences, 22(1), 164–179. https://doi.org/10.22037/ijps.v22i1.48617

References

1. Stegemann, S.; Leveiller, F.; Franchi, D.; de Jong, H.; Lindén, H. When Poor Solubility Becomes an Issue: From Early Stage to Proof of Concept. Eur. J. Pharm. Sci. 2007, 31 (5), 249–261.

2. Li, L., Zhou, C. H., & Xu, Z. P. (2018). Self-Nanoemulsifying Drug-Delivery System and Solidified SelfNanoemulsifying Drug-Delivery System. In Nanocarriers for Drug Delivery: Nanoscience and Nanotechnology in Drug Delivery (pp. 421–449).

3. Patel, J.; Kevin, G.; Patel, A.; Raval, M.; Sheth, N. Design and Development of a Self-Nanoemulsifying Drug Delivery System for Telmisartan for Oral Drug Delivery. Int. J. Pharm. Investig. 2011, 1 (2), 112–118.

4. Yulianto, A. N.; Widyaningsih, W.; Wahyuningsih, I. Effectiveness of SNEDDS to Increased Oral Bioavailability in Antihypertension Agents: A Review. J. Adv. Zool. 2023, 44 (3), 473–483.

5. Buya, A. B.; Beloqui, A.; Memvanga, P. B.; Préat, V. Self-Nano-Emulsifying Drug-Delivery Systems: From the Development to the Current Applications and Challenges in Oral Drug Delivery. Pharmaceutics 2020, 12 (12), 1194.

6. Srikanth Reddy, S. A Comprehensive Review on Self-Nano Emulsifying Drug Delivery Systems: Advancements and Applications. Int. J. Pharm. Sci. Drug Res. 2020, 12 (5), 576–583.

7. Morakul, B. Self-Nanoemulsifying Drug Delivery Systems (SNEDDS): An Advancement Technology for Oral Drug Delivery. Pharm. Sci. Asia 2020, 47 (3), 205–220.

8. Ceppi P, Papotti M, Monica V, Lo Lo Iacono M, Saviozzi S, Pautasso M. Effects of SRC kinase inhibition induced by dasatinib in non-small cell lung cancer cell lines treated with cisplatin. Mol Cancer Ther. 2009;8(11):3066-74.

9. Drugs@FDA. FDA Approved Drugs. Available online: https://www.accessdata.fda.gov/scripts/cder/daf/ (accessed on 5 July 2022).

10. Agrawal M, Garg RJ, Cortes J, Quintas Cardama A. Tyrosine kinase inhibitors: the first decade. Curr Hematol Malig Rep. 2010; 5(2):70-80.

11. Gore L, Kearns PR, de Martino ML, Lee CADS, De Souza CA, Bertrand Y. Dasatinib in pediatric patients with chronic myeloid leukemia in chronic phase: results from a phase II trial. J Clin Oncol. 2018; 36(13):1330-8.

12. Wang C, Wang M, Chen P, Wang J, Le Y. Dasatinib nanoemulsion and nanocrystal for enhanced oral drug delivery. Pharmaceutics. 2022; 14(1):197.

13. Muthadi RR, Kumar SG. A systematic review on supersaturable self-nano emulsifying drug delivery system: a potential strategy for drugs with poor oral bioavailability. Int J Appl Pharm. 2022;14(3):16-33.

14. Schmied FP, Bernhardt A, Engel A, Klein S (2022) A customized screening tool approach for the development of a self-nanoemulsifying drug delivery system (SNEDDS). AAPS PharmSciTech 23(1):1–6.

15. Date, A.; Nagarsenker, M. Design and evaluationof self-nanoemulsifying drug delivery systems (SNEDDS) for cefpodoxime proxetil. Int. J. Pharm. 2007, 329, 166–172.

16. Patel, A.; Vavia, P. Preparation and in vivo evaluation of SMEDDS (self-microemulsifying drug delivery system) containing fenofibrate. AAPS J. 2007, 9, 344–352.

17. Divyakumar, B.; Priyanka, B.; Kiran, B. Formulation and evaluation of self microemulsifying drug delivery system of low solubility drug for enhanced solubility and dissolution. Asian J. Biomed. Pharm. Sci. 2012, 2, 7–14.

18. Azeem A, Rizwan M, Ahmad FJ, Iqbal Z, Khar RK, Aqil M, et al. Nanoemulsion components screening and selection: A technical note. AAPS PharmSciTech 2009;10:69-76.

19. Khalid, K. W.; Abd Alhammid, S. N. Preparation and in-vivo Evaluation of Ticagrelor Oral Liquid Self nano-emulsion. J. Pharm. Negat. Results 2022, 13 (3), 274.

20. Kulkarni, M.; Goge, N.; Date, A. A. Self-Nanoemulsifying Drug Delivery Systems: Formulation Insights, Applications and Advances. Adv. Pharm. Bull. 2020, 10 (3), 339–351.

21. Alghananim, A.; Özalp, Y.; Mesut, B.; Serakinci, N.; Özsoy, Y.; Güngör, S. A Solid Ultra Fine Self-Nanoemulsifying Drug Delivery System (S-SNEDDS) of Deferasirox for Improved Solubility: Optimization, Characterization, and In Vitro Cytotoxicity Studies. Pharmaceuticals 2020, 13 (8), 162.

22. Reddy, S. M.; Baskarla, S. A Review on Formulation and Development of Solid Self-Nano Emulsifying Drug Delivery Systems. Int. J. Pharm. Sci. Nanotechnol. 2021, 14 (4), 5519–5528.

23. Zeng, L.; Zhang, Y. Development, optimization and in vitro evaluation of norcantharidin loadedself-nanoemulsifying drug delivery systems (NCTD-SNEDDS). Pharm. Dev. Technol. 2017, 22 (3), 399− 408.

24. Sabri, L. A.; Hussein, A. A. Oral Liquid Self-nanoemulsion of Nebivolol: Formulation and In-Vitro Characterization for Dissolution Rate Enhancement. Int. J. Drug Delivery Technol. 2021, 11 (3), 1083− 1091.

25. Jain, S.; Bansal, A. K.; Mishra, N.; Jain, R.; Saraf, D. Self-Nanoemulsifying Formulation for Oral Delivery of Sildenafil: Effect on Physicochemical Attributes and In Vivo Pharmacokinetics. Drug Deliv. Transl. Res. 2023, 13, 839–851.

26. Putri, S. A.; Winarti, L. Meloxicam Self-Nano-Emulsifying Drug Delivery System with Surfactants Combination: Formulation and In Vitro Release Model. Pharm. Educ. 2023, 23 (1), 18–24.

27. Kumar, M.; Pathak, K.; Verma, T.; Yadav, D. Solid Self-Nanoemulsifying Drug Delivery Systems of Nimodipine: Development and Evaluation. Future J. Pharm. Sci. 2024, 10, 87.

28. Nair, A. B.; Jacob, S.; Vuddanda, P. R.; Kumar, A.; Sreeharsha, N.; Morsy, M. A.

Formulation and Evaluation of Self-Nanoemulsifying Drug Delivery System Derived Tablet Containing Sertraline. Pharmaceutics 2022, 14 (2), 336.

29. Tashish, A. Y.; Shahba, A. A.-W.; Alanazi, F. K.; Kazi, M. Unlocking the Potential: Synergistic Effects of Solid SNEDDS and Lyophilized Solid Dispersion to Enhance Stability Attributes. Front. Biosci. (Landmark Ed.) 2023, 28 (12), 349.

30. Mohd, A. B.; Sanka, K.; Bandi, S.; Diwan, P. V.; Shastri, N. Solid Self-Nanoemulsifying Drug Delivery System (S-SNEDDS) for Oral Delivery of Glimepiride: Development and Antidiabetic Activity in Albino Rabbits. Drug Deliv. 2015, 22 (4), 499–508.

31. Sarwar, B.; Katare, O.; Sumant, S.; Singh, B. Solid self-nanoemulsifying systems of olmesartan medoxomil: Formulation development, micromeritic characterization, in vitro and in vivo evaluation. Powder Technol. 2016, 294, 93–104.

32. Sharma, P.; Singh, S. K.; Pandey, N. K.; Rajesh, S. Y.; Bawa, P.; Kumar, B.; Gulati, M.; Singh, S.; Verma, S.; Yadav, A. K.; Wadhwa, S.; Jain, S. K.; Gowthamarajan, K.; Malik, A. H.; Gupta, S.; Khursheed, R. Rational Design and Development of a Soluble Mesoporous Carrier for the Solidification of a Preconcentrated Self-Nanoemulsion Formulation. ACS Omega 2023, 8 (1), 1234–1245.

33. Nazlı, H.; Mesut, B.; Özsoy, Y. In Vitro Evaluation of a Solid Supersaturated Self-Nanoemulsifying Drug Delivery System (Super-SNEDDS) of Aprepitant for Enhanced Solubility. Pharmaceuticals 2021, 14 (11), 1089.

34. Ghosh, D.; Singh, S. K.; Khursheed, R. Impact of Solidification on Micromeritics Properties and Dissolution Rate of Self-Nanoemulsifying Delivery System Loaded with Docosahexaenoic Acid. Drug Dev. Ind. Pharm. 2020, 46 (4), 597–605.

35. Buya, A. B.; Beloqui, A.; Memvanga, P. B.; Préat, V. Self-Nano-Emulsifying Drug-Delivery Systems: From the Development to the Current Applications and Challenges in Oral Drug Delivery. Pharmaceutics 2020, 12 (12), 1194.

36. Morani, D. O.; Patil, P. O. Review on Multifunctional Nanotherapeutics for Drug Delivery, Tumor Imaging, and Selective Tumor Targeting by Hyaluronic Acid Coupled Graphene Quantum Dots. Curr. Nanosci. 2024, 20 (1), 89–108.

37. Morani, D.; Patil, P.; Jain, A. Recapitulation of Cancer Nanotherapeutics. Curr. Nanomed. 2021, 11 (1), 3–15.

38. Morani, D. O.; Patil, P. O. Formulation and Evaluation of Hyaluronic Acid and Adipic Acid Dihydrazide Modified Graphene Quantum Dot-Based Nanotherapeutics for Paclitaxel-Targeted Delivery in Breast Cancer. Futur. J. Pharm. Sci. 2025, 11 (1).

39. O. Morani, D.; Rane, B. Review on Different Multimodal Approaches for Multifactorial Cancer Disease. Asian J. Pharm. Technol. 2024, 264–270.

40. Sudhakar Patil, V.; Rupa Bavaskar, K.; Omprakash Morani, D.; Suresh Jain, A. Review on Hyaluronic Acid Functionalized Sulfur and Nitrogen Co-Doped Graphene Quantum Dots Nano Conjugates for Targeting of Specific Type of Cancer. Adv. Pharm. Bull. 2024, 14 (2), 266–277.

41. Morani, D. O.; Patil, P. O. Preparation, Characterization, and Cytotoxicity Study of Nitrogen-Doped Graphene Quantum Dots Functionalized Hyaluronic Acid Loaded with Docetaxel-Catalyzed Nanoparticles for Breast Cancer Imaging and Targeting in Vitro. J. Macromol. Sci. Phys. 2024, 1–25.

  • Abstract Viewed: 63 times
  • IJPS_Volume22_Issue1_Pages164-179 Downloaded: 70 times

Download Statastics

Developed By

Open Journal Systems

Information